MACK-3 (homeostasis model assessment, aspartate aminotransferase, CK-18) is a score incorporating CK-18 and is specifically designed to predict the presence of fibrotic NASH, defined as active NASH with concomitant stage F2 or F3 fibrosis (16). This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.